iviGene

iviGene Corporation was an early-stage biotechnology company focused on the discovery of novel genomic and proteomic biomarkers for the development of vaccines, diagnostics, and therapeutics. Based in Alachua, Florida, the company utilized its proprietary platform technologies, In Vivo Induced Antigen Technology (IVIAT) and Change Mediated Antigen Technology (CMAT), to identify genes and proteins expressed specifically during active human infection or disease progression. These platforms allowed for the rapid screening of targets without the need for animal models, significantly accelerating the discovery process for conditions such as tuberculosis and various cancers. In November 2006, iviGene was acquired by Oragenics, which integrated iviGene's intellectual property into its own pipeline of oral probiotics and anti-infective products.